2026 MSK Pulmo-Oncology Symposium

Pulmo-oncology is an emerging discipline at the intersection of pulmonary medicine and oncology, playing a critical role in the clinical care of patients with cancer. The respiratory system is often impacted by direct cancer involvement and toxicities stemming from the use of anti-neoplastic agents. Pre-existing pulmonary disorders affect patient outcomes and management decisions. Effective clinical management of pulmonary complications of cancer and its therapies requires an interdisciplinary approach.

Now in its fourth year, this symposium brings together globally recognized experts from multiple disciplines to present the latest advances in cancer therapies and best practices in the evaluation and management of lung disease. Through state-of-the-art presentations and interdisciplinary, case-based discussions, this symposium will explore key topics related to the care of cancer patients with pulmonary comorbidities and complications arising from cancer or its treatments.

Key Topics Include 

• State-of-the-art updates in lung cancer treatment

• Clinical strategies for management of drug toxicities, symptoms, and co-existing pulmonary conditions

• Emerging AI screening and continuous monitoring technologies as well as social media modalities into clinical management for cancer patients at risk of pulmonary complications

Complex cases will be integrated throughout the program, with dedicated time for interactive, multidisciplinary panel discussions to foster meaningful engagement between participants and faculty.

This symposium is intended for healthcare professionals in pulmonology, hematology/oncology, and related disciplines involved in the care of patients with cancer or those with a special interest in this area.

1. Describe the role of the pulmonologist in diagnosis and management of cancer related pulmonary complications
2. Identify state of the art diagnostic and treatment strategies for management of lung cancer
3. Implement strategies for diagnosis and management of non-infectious pulmonary complications of cancer directed therapies
4. Discuss multidisciplinary approach in complex patients
5. Implement approaches to symptom management and management of long term pulmonary complications of cancer treatment
6. Integrate emerging AI screening and continuous monitoring technologies as well as social media modalities into clinical management for cancer patients at risk of pulmonary complications.

We are pleased to offer flexible learning options for this course. Participants may attend the live event in person or virtually, or register for on demand access available after the live event.

Registration Options

• Register for Live Participation (In-Person or Virtual)

• Register for On Demand Access

Registration Fees

• Physicians (MDs, PhDs, DOs): $300

• Advanced Practice Providers: $250

• Residents and Fellows: $100

• Nurses and Other Healthcare Professionals: $150

• Industry Professionals: $525*

• MSK Employees: Complimentary**

Discounted registration is available for select groups, including trainees, MSK alumni/affiliates, and participants from low- and lower-middle-income countries. View our Policy on Registration Discounts for more information.

For cancellation details, please review our Cancellation Policy.

*An industry professional is defined as any individual, irrespective of their provider type (such as MDs, PhDs, APPs, RNs, etc.) that is employed by an ineligible company. Review our Registration Policy for Industry Professionals for more information.
**MSK employees receive complimentary registration for all CME programs by signing in with MSK credentials (SSO).

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

AMA Credit Designation Statement

This activity is expected to offer AMA PRA Category 1 Credit(s)™. Final credit designation will be determined at a later date.

MOC/CC Recognition Statements

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

• Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and

• credit toward the CME and Self-Assessment of the American Board of Thoracic Surgery’s (ABTS) Maintenance of Certification program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABTS MOC/CC credit.

ANCC Nursing Continuing Education*

Nursing contact hours pending.

*Please note that ANCC Nursing contact hours are available only to participants of the live course. Nursing credit is not available for the on demand version.

MSK Symposium Directors 

Leontine J.R. van Elden, MD, PhD
Associate Attending, Pulmonary Service;
Assistant Professor of Clinical Medicine, Weill Cornell Medical College

Elizabeth Yogiaveetil, MD
Assistant Attending, Pulmonary Service;
Assistant Professor of Clinical Medicine, Weill Cornell Medical College

Christina M. Hess, AGACNP-BC
Nurse Practitioner, Pulmonary Service


MSK Symposium Planning Committee

Michelle Cavuoto, MA, RN, OCN®
Clinical Nurse IV

Mohit Chawla, MD, FCCP
Chief, Pulmonary Service

Catherine Oberg, MD
Assistant Attending, Pulmonary Service

Gopi I. Patel, MD
Assistant Attending, Pulmonary Service

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.